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ABSTRACT The K+ diffusion potential-induced association of synthetic model peptides carrying a single positive charge originating
from the NH2-terminal amino function with large unilamellar vesicles (LUV) consisting of phosphatidylcholine (PC) has been
reported previously (de Kroon, A. 1. P. M., J. de Gier, and B. de Kruijff. 1989. Biochim. Biophys. Acta. 981 :371-373). To determine
the vesicle localization of the associated peptides, fluorescence measurements utilizing the peptides' tryptophan residue as
intrinsic fluorescent probe were performed. The application in these measurements, of vesicles that exhibit an asymmetric
transbilayer distribution of brominated PC which is a quencher of tryptophan fluorescence, unequivocally demonstrated that the
peptide H3N+-AIMLWA-Ome (AlXme+) is accumulated in the interface of the inner leaflet of the vesicle membrane in response to
the valinomycin-induced K+ diffusion potential (negative inside). The relative contributions of the membrane potential (A+) and the
pH gradient (ApH, acidic inside) induced by the K+ diffusion potential, to the process have been assessed. An analysis of the pH
and ApH dependencies of the process demonstrated that the K+ diffusion potential-induced peptide accumulation is largely
determined by a redistribution of peptide according to the transbilayer pH gradient, in agreement with a translocation across the
vesicle membrane of the neutral, deprotonated form of the peptide. The general validity of the mechanism proposed for the
vesicle-uptake of AlXme+ has been examined by extending the experiments to peptide analogues with a single negative charge
and to peptides with two positive charges, and by investigating the effect of incorporating the acidic phospholipid cardiolipin (CL)
into the LUV. The incorporation of CL appeared not to affect the K+ diffusion, potential-induced vesicle uptake of AlXme+. The
peptide H3N+-RMLWA-Ome (RXme2") showed a small ApH independent fluorescence response to the Aqi upon raising the CL
content of the vesicles to 25%.
INTRODUCTION
Peptide-lipid interactions have been implied to play a
role in biological processes that involve membrane
binding or transmembrane passage of peptides and
proteins (see Sargent and Schwyzer, 1986; Jones et al.,
1990). The study of peptide-lipid interactions in model
systems contributes to the understanding of the mecha-
nisms of these processes. Some important factors govern-
ing the mode and the extent of peptide-lipid bilayer
interaction are the hydrophobicity of the peptide, the
charge of the peptide, and related to the latter the
surface charge of the membrane. In a recent model
system study, the contribution of each of these factors to
the membrane affinity and membrane topology of a set
of related synthetic peptides has been investigated using
the fluorescence properties of the peptides' intrinsic
tryptophan residue (de Kroon et al., 1990).
Another important parameter likely to influence the
interaction of peptides or proteins with the lipid phase
of biomembranes is provided by the electrochemical
gradients existing across most biological membranes.
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We have studied this possibility in model systems that
consist of the synthetic peptides already mentioned, and
of phospholipid vesicles exhibiting ion gradients that
give rise to membrane potentials (A*) and pH gradients
(ApH).
Previously, the effect of a valinomycin-induced K+
diffusion potential (negative inside) on the vesicle-
association of the peptides AXme+ and AIXme+ (see
Table 1 for the abbreviations) has been reported (de
Kroon et al., 1989). Both peptides carry a single positive
charge arising from the NH2-terminal amino group and
show a very modest affinity for phosphatidylcholine (PC)
vesicles as such (see also de Kroon et al., 1990).
However, upon application of a K+ diffusion potential,
the peptide-vesicle association as assayed by minicol-
umn gel filtration, is strongly increased, with the extent
of the association depending on the applied K+ gradient
and on the hydrophobicity of the peptide.
This result raised a number of questions that have
been addressed in the present paper. The question of
the localization of the associated peptide molecules has
been elucidated in tryptophan fluorescence measure-
ments employing PC vesicles that exhibit an asymmetric
transbilayer distribution of brominated PC. Brominated
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TABLE 1 Peptides used
Abbreviation* Sequence
AXme+ +N-Ala-Met-Leu-Trp-Ala-Ome
AIXme+ +N-Ala-Ile-Met-Leu-Trp-Ala-Ome
RXme2+ +N-Arg+-Met-Leu-Trp-Ala-Ome
AXetN2+ +N-Ala-Met-Leu-Trp-Ala-ONH
(CH2)2NH3+
bocAX- t-Boc-Ala-Met-Leu-Trp-Ala-0O
bocAIX- t-Boc-Ala-Ile-Met-Leu-Trp-Ala-0O
*The abbreviation X denotes the sequence Met-Leu-Trp-Ala. Other
amino acids are indicated by the one-letter symbols; boc indicates the
coupling of a tert-butyloxycarbonyl group to the amino-terminus, me,
methylation of the carboxyl group, and etN, the attachment of
diaminoethane to the COOH-terminus.
phospholipids are short range quenchers of tryptophan
fluorescence (Bolen and Holloway, 1990; de Kroon et
al., 1990), and have been used previously in a similar
experimental approach to solve the membrane topology
of cytochrome b5 (Everett et al., 1986).
The mechanism of the K+ diffusion potential-induced
peptide-vesicle association was addressed by determin-
ing the relative contributions to the process of the
membrane potential itself and of the pH gradient
evoked by the membrane potential, while varying the pH
of the system. Similar studies on the K+ diffusion
potential-induced vesicle-uptake of the local anaesthetic
dibucaine and the biogenic amine dopamine revealed a
major contribution to the uptake by the concurring
transmembrane pH gradient (Mayer et al., 1988; Bally et
al., 1988).
The generality of the ion gradient-induced peptide-
vesicle association was examined by extending the exper-
iments to peptides carrying more than one positive
charge, and to vesicles with a negative surface charge as
is often found in biomembranes. Furthermore, the
applicability of the findings was tested in systems of the
opposite polarity, which consist of anionic peptide ana-
logues and vesicles exhibiting reversed ion gradients
(i.e., Nain+/Keut+). A mechanism for the ion gradient-
induced peptide-vesicle association is proposed and the
relevance of this study for some biological processes is
indicated.
MATERIALS AND METHODS
Peptides
The synthesis, modification, purification and nomenclature of the
model peptides employed has been described previously (de Kroon et
al., 1990). The peptides and their nomenclature are summarized in
Table 1. Stock solutions of peptides were prepared in dimethylsulfox-
ide (DMSO), the concentrations were determined using En" = 5.6
mM-,cm-'.
Phospholipids
Egg-phosphatidylcholine (PC) and beef heart cardiolipin (CL) were
purified as described (Van Duijn et al., 1984; Smaal et al., 1985). The
synthesis, purification, and characterization of the brominated phos-
phatidylcholines (BrPC), 1-palmitoyl-2-(2-bromohexadecanoyl)-phos-
phatidylcholine (2-BrPC), 1-palmitoyl-2-(n,n +-dibromostearoyl)phos-
phatidylcholine (6,7-Br2PC, 9,10-Br2PC, 11,12-Br2PC) and 1,2-bis-(9,
10-dibromostearoyl)phosphatidylcholine (Br4PC) has been described
(de Kroon et al., 1990). N-(5-dimethylaminonaphtalene-1-sulfonyl)di-
palmitoyl-phosphatidylethanolamine (DNS-PE) was purchased from
Molecular Probes Inc. (Eugene, OR).
Miscellaneous
Phosphatidylcholine-specific transfer protein (PCTP) was purified
from bovine liver (Westerman et al., 1983) and stored at 0.8 mg/ml in
50% glycerol containing buffer at -20°C. N-(11-(9-carbazole)und-
ecanoyl)glucosaminic acid (CUGA) was synthesized by coupling
glucosaminic acid (Sigma Chemical Co., St. Louis, MO) to 11-(9-
carbazole)undecanoic acid (Molecular Probes Inc.) according to
Everett et al. (1986). The product revealed a single fluorescent spot
upon thin layer chromatography and was not further purified. A
- 1-mM stock solution of CUGA in water was prepared on weight
basis. Tryptophan-N-formylated gramicidin (NFG) was prepared as
reported (Killian et al., 1985). Valinomycin was purchased from
Boehringer Mannheim Corp. (Mannheim, Germany). Carbonylcyanide-
p-trifluoromethoxyphenylhydrazone (FCCP) was obtained from Sigma.
3,3'-Diethyl-thiadicarbocyanine iodide [diS-C2-(5)] was obtained from
Molecular Probes. [3H]Tetraphenyl phosphoniumbromide (TPP+),
['4C]methylamine hydrochloride (MeAm) and ['4C]inuline were pur-
chased from New England Nuclear (Boston, MA). [3H]Cholesteryl-
oleoylether and ['4C]dioleoylphosphatidylcholine (DOPC) were from
Amersham Corp. (Arlington Heights, IL). All other chemicals were
analytical grade or better.
Preparation of large unilamellar
vesicles (LUV) and generation of ion
gradients
Dry lipid films were hydrated in the appropriate buffer by vortexing.
The dispersions were frozen and thawed ten times and subsequently
extruded ten times through 400 nm or 200 nm pore size polycarbonate
filters as described (Hope et al., 1985). When using egg PC at a
concentration of 20 mM, this procedure in our hands yielded LUVET
400 with a trapped volume of 3.0 0.1 pL/,mol and LUVET 200 with a
trapped volume of 2.0 + 0.1 plA4Lmol respectively, as determined by
trapping ['4C]inuline (Mayer et al., 1986a). Tournois et al. (1990)
found that at least 80% of the lipids of LUVET 400 resides in the
outermost bilayer. LUVET 400 were used in all experiments unless
stated otherwise.
Transmembrane K+iJNa'., chemical gradients were obtained by
preparing the vesicles in 150 mM K2SO4, 20mM Hepes adjusted to pH
7.0 with KOH, and removing the untrapped buffer by passing the
vesicles through a Sephadex G 50 (medium) column eluted with 150
mM Na2SO4, 20 mM Hepes adjusted to pH 7.0 with NaOH (de Kroon
et al., 1989). To increase the buffering capacity, some experiments
were carried out in phosphate buffer. Vesicles were prepared in 200
mM KPi and the external K+ was replaced by Na+ on a Sephadex
column eluted with 200 mM NaPi. The desired pH values in the range
6-8 were obtained by mixing the appropriate amounts of the mono-
and dibasic salt. When pH values in the range 7.5-9.0 were required,
20 mM Tricine was used as buffer. When using CL containing vesicles,
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2 mM EDTA was included in the buffers. Transmembrane Najn+/KO,+
gradients were created by diluting vesicles prepared in 150 mM
Na2SO4, and 10 mM each of Hepes, MES, and glutamic acid (abbrevi-
ated as 10 mM HMG) at the desired pH in the range 4-7, into 150 mM
K2SO4, 10mM HMG at the same pH.
Phospholipid concentrations of vesicle preparations were deter-
mined by the method of Rouser et al. (1970). Amounts and concentra-
tions of CL are always expressed on phosphorus basis. When applying
phosphate buffer, vesicles were radiolabeled with ['4C]DOPC or
[3H]cholesteryloleoylether to enable quantitation.
Determination of peptide-vesicle
association
Peptide-vesicle association was assayed either discontinuously in a
direct binding assay employing gelfiltration through minicolumns, or
on-line, in fluorescence experiments utilizing the tryptophan residue
as an intrinsic fluorescent probe.
In the first method, 0.1 mM of peptide from a -20-mM stock
solution in DMSO was added at time zero to a 1-mM vesicle
suspension exhibiting the appropriate ion gradient (lipid/peptide
molar ratio, Ri, of 10). Where employed, valinomycin was added at t =
0 from a 0.1 or 1 mg/ml solution in ethanol, and FCCP from a 0.01
mg/ml solution in ethanol. At several time points after starting the
incubation 150-p.l aliquots were withdrawn and within 10 s centrifuged
through 1.5-ml Sephadex G 50 (medium) minicolumns (2 min, 300 * g)
to separate free from associated peptide (Hope et al., 1985). The
minicolumns were always preequilibrated with the external buffer used
in the peptide-vesicle incubation. Quantitation of vesicle-associated
peptide was accomplished by analysis of the filtrates for phospholipid
by phosphorus determination or scintillation counting, and for peptide
by measuring the tryptophan fluorescence intensity in 0.5% (wt/vol)
sodium cholate containing buffer using an SLM-Aminco SPF-500 C
fluorimeter and 0.5-ml cuvettes (de Kroon et al., 1989).
Ion gradient-induced peptide-lipid vesicle interaction was moni-
tored continuously by recording the peptide's fluorescence emission at
340 nm (band pass 11 nm) on a fluorimeter (MPF3, Perkin-Elmer
Corp., Norwalk, CT) under continuous stirring and at room tempera-
ture. The excitation wavelength was 280 nm (band pass 6 nm). Unless
stated otherwise, 2 I1M of peptide from a 2-mM stock solution in
DMSO was added at t = 0 to 300 LM LUV of the appropriate
composition and exhibiting an ion gradient (R, = 150). Under these
conditions the vesicle blank (scatter) constituted -20% of the total
signal. When required valinomycin and FCCP were added at t = 0.
NFG instead of gramicidin was used to dissipate ion gradients as it
does not contribute to the fluorescence signal. Where applied this
compound was added to a 1/400 NFG/phospholipid ratio from a
0.5-mM solution in DMSO. Fluorescence changes are always ex-
pressed as F/Fo with F the measured fluorescence and Fo the fluores-
cence at time zero, both corrected for the vesicle blank.
To enable a more sensitive detection of possible ion gradient-
induced changes in peptide-vesicle interaction in cases where the
methods described above were not conclusive, a tryptophan-dansyl
resonance energy transfer assay (Vaz et al., 1977) was applied. In these
experiments 2% (mol/mol) DNS-PE was incorporated into the vesi-
cles. The time dependent change of DNS-PE fluorescence upon
addition of 20 ,uM peptide to 200 FLM LUV (Ri = 10) was recorded at
520 nm. Other conditions were as stated above for the recording of
tryptophan fluorescence. A correction was applied for a vesicle blank,
i.e., vesicles devoid of DNS-PE, which never exceeded 5% of the total
signal.
Determination of A*4 and ApH
Membrane potentials (negative inside) and transmembrane pH gradi-
ents (acidic inside) were assessed by measuring the transbilayer
distribution of [3H]TPP+ and ['4C]MeAm employing the minicolumn
separation method described above (Rottenberg, 1979; Hope et al.,
1985; Redelmeier et al., 1989). [3H]TPP+ was added at 1 ,uCi/ml
(corresponds to 0.026 nM) and ['4C]MeAm at 0.24 ,uCi/ml (5.8 ,uM)
final concentrations to the vesicle suspensions in the presence or
absence of peptide. A correction was made for the background
association of the probes, which was obtained by applying the same
conditions to the vesicles in the absence of an ion gradient. This
background association never exceeded 1.5% of the total amount of
TPP' present, for MeAm it never exceeded 0.5%. Calibration of the
TPP+ probe by varying the external K+ concentration and applying the
Nernst equation (Rottenberg, 1979), revealed that this probe overesti-
mated the value of A* when applied to the LUVET 400 system (data
not shown), probably due to additional probe binding to the vesicle
interior (Lolkema et al., 1982; cf Redelmeier et al., 1989). Therefore,
and because of the inherent inaccuracy of the method at high
potentials, the TPP+ data were not converted into membrane potential
values. Instead, log ([TPP+]ji/[TPP'I0.,) was used as a relative measure
for the membrane potential. The methylamine distribution was trans-
lated to a ApH value according to ApH = log ([MeAm]jj/[MeAm]O).
Redelmeier et al. (1989) have demonstrated that the MeAm distribu-
tion provides an accurate measure of the pH gradient between the
interior and exterior aqueous compartments.
For a fast routine determination of A* the fluorescent carbocyanine
probe diS-C2-(5) was used (Sims et al., 1974). Briefly, 25 P,M PC from a
peptide-vesicle association experiment was added to 1.5 F.M diS-C2-(5)
in the appropriate buffer and the response of the fluorescence
intensity (X = 622 nm, Xem = 660 nm) was recorded. This method
enabled a qualitative assessment of the degree of dissipation of the
membrane potential. The incorporation of BrPC into the vesicles did
not interfere with this method.
Preparation and characterization of
vesicles with an asymmetric
transbilayer distribution of BrPC
Following Everett et al. (1986), the membrane topology of the
associated peptides was determined using vesicles with an asymmetric
transbilayer distribution of brominated PC, which is a quencher of
tryptophan fluorescence. PCTP was used to randomize the BrPC
composition of the outer leaflets of donor and acceptor vesicles
(Dawidowicz and Rothman, 1976). LUV were used as acceptor
vesicles and sonicated vesicles (SUV) as donor vesicles to enable
separation by centrifugation. Depending on the experimental condi-
tions LUVET 400 and LUVET 200 were applied.
PCot,/Br4PC1nLUV
Br4-PC LUVET 200, 5 ,umol, labeled with 1.0 pCi (10 nmol) of the
exchangeable marker [14C]DOPC was incubated with a 20-fold excess
of (100 ,umol) eggPC SUV labeled with 20 ,uCi (0.4 nmol) of the
unexchangeable marker [3H]cholesteryloleoylether and prepared as
described elsewhere (de Kroon et al., 1990), in the presence of 2.5
p.g/ml PCTP at a total lipid concentration of 0.5 mM overnight at room
temperature under continuous stirring. Both LUV and SUV were
prepared in 150 mM K2SO4, 20 mM Hepes pH 7.0 and collected from
respectively the pellet and the supernatant of a 1 h 170,000 * g..
centrifugation using a 60-Ti rotor in an ultracentrifuge (L5-65,
Beckman Insts., Carlsbad, CA). After the incubation the LUV were
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recovered by centrifugation at the same speed and the incubation was
repeated with freshly prepared SUV. After pelleting, the LUV were
resuspended in K2SO4 buffer and centrifuged 1 h at 140,000 * g.. to
remove copelleted SUV. The final pellet was carefully rinsed twice
with 150 mM Na2SO4, 20 mM Hepes pH 7.0, before resuspending it in
this buffer to create a K+/Na+ ion gradient. Subsequently, these LUV
were used in the fluorescence experiments.
Typically this procedure resulted in a LUV preparation (yield: 60%)
containing a SUV contamination amounting to 10% of the total lipid.
The asymmetry of the LUV was estimated by two independent
methods. Scintillation counting demonstrated the exchange of 45% of
the [14C]DOPC initially present in the LUV. Provided that the
exchange equilibrium attained for DOPC and Br4PC is similar, and
assuming a 47/53 phospholipid distribution between inner and outer
leaflet of the LUVET 200 based on the vesicle size (Mayer et al.,
1986a), this would indicate that the asymmetric LUV retain 15%
Br4PC in their outer leaflet.
Everett et al. (1986) have introduced the fluorescent amphiphile
CUGA as a suitable asymmetry probe. LUVET 200 with different
amounts of Br4PC incorporated were used to calibrate the quenching
ofCUGA fluorescence. 20 ,uM of vesicles was added to 2.5 ItM CUGA
in buffer under continuous stirring at room temperature and the
fluorescence intensity (X,,, = 300 nm, X,,, = 353 nm) was read after 2
min. Taking into account the SUV contamination of the LUV
preparation, it could be shown by the CUGA method that the
asymmetric LUV contained at most 20% Br4PC in the outer leaflet, in
good agreement with the number deduced from scintillation counting.
6,7-Br2PCout/PC,nLUV
Briefly, 4 ,umol eggPC LUV and 9 ±Lmol eggPC/6,7-Br2PC 3/1 (molV
mol) SUV labeled with both 2 1Ci [14C]DOPC and 4 ,Ci [3H]cho-
lesteryloleolether were incubated overnight with PCTP as described
above. LUV and SUV had been precentrifuged for 1 h at 260,000 - g,
and, respectively, the pellet and supernatant were used. To efficiently
spin down the PC LUV, the incubation was carried out in 100 mM
K2S04 instead of 150mM K2SO4 buffer. For the same reason, LUVET
400 were used and not LUVET 200. 6,7-Br2PC and not Br4PC was used
and incorporated to only 25% in the donor SUV to avoid copelleting of
SUV. After one round of exchange, the pellet fraction of a 260,000 -
g.. centrifugation was passed through a Sephadex G50 column eluted
with 100 mM Na2SO4, 20 mM Hepes pH 7.0 to generate the ion
gradient before use in the fluorescence experiments.
The recovery of LUV in the pellet fraction was 60% and the
contamination with SUV amounted to 30% of the total lipid. Based on
scintillation counting of pellet and supernatant it was calculated that
12% of the ['4C]DOPC initially present in the SUV had been
exchanged from SUV to LUV. Under the assumption made above for
exchange efficacy and taking a phospholipid distribution between
inner and outer leaflet of 48/52 for LUVET 400, this number would
correspond to a 13% 6,7-Br2PC content in the outer leaflet of the
resulting asymmetric LUV. Using CUGA as asymmetry probe after
calibration with 6,7-Br2PC containing LUVET 400 in the presence of
30% SUV containing 25% 6,7-Br2PC, the 6,7-Br2PC content of the
LUV outer membrane leaflet was determined to be at least 8%.
RESULTS
Localization
In assessing the localization of the associated peptides,
advantage was taken of the fluorescent properties of the
intrinsic tryptophan residue. Fig. 1 shows that the K+
diffusion potential-enhanced vesicle association of
AIXme+ (Table 1) is apparent from an increased fluores-
cence intensity at 340 nm in on-line tryptophan fluores-
cence measurements. The increased emission intensity
which is accompanied by a blue shift of the wavelength
of maximum emission (data not shown), indicates that
the tryptophan enters a different, more hydrophobic
environment. In the absence of an ion gradient, the
addition of PC LUV to AIXme+ to a lipid/peptide molar
ratio of 150 results in an increase of the fluorescence
intensity of <10%, reflecting the low affinity of this
peptide for PC bilayers (de Kroon et al., 1990).
The rate and the extent of the fluorescence increase
induced by the addition of valinomycin to PC LUV
exhibiting a K+/Na+ gradient, depend on the amount of
valinomycin added (shown for val/PC = 10-4 and 10' in
Fig. 1). Whereas, at the lower valinomycin concentra-
tion, the fluorescence increase initially proceeds more
slowly, the maximum emission intensity attainable is
greater than at the higher valinomycin concentration.
The higher fluorescence intensity reached reflects that
the membrane potential is larger and more stable at the
lower valinomycin concentration, as was confirmed by
TPP+ distribution measurements (data not shown). The
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FIGURE 1 Time course of the ion gradient induced tryptophan
fluorescence change at 340 nm of 2 FM AIXme+ added to 300 FM PC
LUV. LUV were prepared in 150 mM K2SO4, 20 mM Hepes pH 7.0
and the untrapped buffer was replaced by 150 mM Na2SO4, 20 mM
Hepes pH 7.0 (see Methods). Data are shown for vesicles experiencing
a K+/Na+ gradient in the absence of ionophores (U), with valinomycin
added to a 10-3 (l) or 10-4 (A) molar ratio with respect to PC, with
both valinomycin and FCCP added to molar ratios of 10-4 and 1.3 - 10-4
with respect to PC (A), and for vesicles with K+ on both sides of the
membrane (0). The ionophores were added at t = 0. The arrow
indicates the addition of NFG to a 1:400 NFG/PC molar ratio.
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dependence of the initial kinetics of the fluorescence
increase on the valinomycin concentration is most likely
due to the difference in lagtime for achieving a homoge-
neous valinomycin-vesicle distribution and was observed
earlier for the membrane potential probe safranine 0
(Woolley et al., 1987). These data allow the conclusion
that the ionophore only contributes to the peptide-
vesicle association by switching on the membrane poten-
tial. The addition of valinomycin together with the
proton ionophore FCCP at a low concentration (FCCP/
PC = 1.3- 10-4) further enhances the fluorescence in-
crease (Fig. 1) and provides a first clue for a role of the
pH gradient in the process. The addition of FCCP alone
does not significantly affect the fluorescence level. The
reversibility of the peptide-vesicle association is evi-
denced by the fast drop in fluorescence intensity upon
dissipation of the ion gradient by NFG (Fig. 1; cf de
Kroon et al., 1989).
The susceptibility of tryptophan fluorescence to
quenching by brominated PC incorporated into the
LUV experiencing a membrane potential shows that the
peptide AIXme+ is inserted into the membrane. The
quenching profile depicted in Fig. 2 demonstrates that
AIXme+ attains an interfacial localization. It should be
stated that the quenching efficiency by 2-BrPC is an
underestimate of its actual value as the bromine content
of this lipid is only 37% (de Kroon et al., 1990).
Furthermore, a comparison of the quenching efficiency
of 2-BrPC to that of the dibromo-PC is inherently
impeded by the different number of bromines per
molecule (Bolen and Holloway, 1990).
To distinguish between the possibility that the peptide
adsorbs at the outer vesicle surface and the possibility
that it accumulates at the interface of the inner mem-
brane leaflet after translocating across the bilayer,
vesicles with an asymmetric transbilayer distribution of
BrPC were used in the fluorescence measurements
(Fig. 3).
Upon addition of valinomycin to asymmetric vesicles
containing 100% Br4PC in the inner, and at least 80%
PC in the outer membrane leaflet, a decrease ofAIXme+
fluorescence is apparent that can be enhanced in the
presence of FCCP (Fig. 3 a) and reversed by adding
NFG (data not shown). In the control experiments using
PC LUV with a symmetric transbilayer distribution of
20% Br4PC, a fluorescence increase is observed (Fig. 3 a)
time (min)
30 T T
-
OD
c._
to
20
10*
2 6,7 9.10 11,12
position bromine(s)
FIGURE 2 Depth dependent quenching efficiency ofAIXme+ fluores-
cence at 30% (mol/mol) brominated PC incorporation into PC LUV
experiencing a valinomycin-induced K+ diffusion potential. Fluores-
cence intensities, F, were measured 30 min after the addition of
valinomycin to a 10-3 molar ratio with respect to PC and the quenching
efficiency was calculated according to (1-F/Fo) 100% with Fo the
fluorescence intensity measured in the absence of brominated PC. The
error bars indicate the absolute error. DiS-C2-(5) measurements
revealed no significant differences in membrane potential stability
upon comparison of LUV with and without 30% of each of the BrPC
incorporated.
FIGURE 3 A K+ diffusion potential applied to PC LUV induces the
quenching of AIXme+ fluorescence by BrPC present in the inner
membrane leaflet (a) but not by BrPC exclusively present in the outer
membrane leaflet (b). (a) Fluorescence change ofAIXme+ in response
to LUVET 200 with an asymmetric transbilayer distribution of 100%
Br4PC in the inner membrane leaflet and < 20% Br4PC and . 80% PC
in the outer membrane leaflet in the absence of an ion gradient (E), in
the presence of a KYn+/Na..,+ gradient after addition ofvalinomycin to a
10'- molar ratio with respect to PC (A) and after addition of both
valinomycin and FCCP to molar ratios of 10'- and 1.3 * 10' with
respect to PC (0). The corresponding closed symbols represent
identical conditions applied to symmetric LUVET 200 with 20%
Br4PC incorporated. (b) Fluorescence change of AIXme+ upon addi-
tion to LUVET 400 containing 6,7-Br2PC exclusively in the outer
membrane leaflet and experiencing a K,0+/Na0u,+ gradient without (E)
and with valinomycin added at t = 0 (A). For comparison the
fluorescence response to PC LUVET 400 (A) and 12.5% 6,7-Br2PC
containing symmetric LUVET 400 (0) exhibiting a valinomycin-
induced K+ diffusion potential is shown; 128 ,uM 25% 6,7-Br2PC
containing SUV (Kjn+/Na..+) was present in these experiments to
mimic the SUV contamination of the asymmetric LUV preparation
(see Methods). The use of 100 mM K2SO4/Na2SO4 instead of 150 mM
in this experiment (see Methods) did not affect the fluorescence
measurements. The val/PC molar ratio was 2 - 10-4; other concentra-
tions as in Fig. 1.
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which is less than that obtained for PC LUV, as expected
in view of the data presented in Fig. 2. Taken together,
these data allow the conclusion that at least part of the
peptide's fluorescence is quenched by bromines in the
inner bilayer leaflet.
Conversely, the membrane potential induces a fluores-
cence increase when applied to asymmetric vesicles
containing 8-13% 6,7-Br2PC exclusively in the outer
leaflet, to an extent that is similar to that obtained in the
control experiment for PC LUV and greater than that
recorded for symmetric 12.5% 6,7-Br2PC containing
vesicles (Fig. 3 b).
The lack of fluorescence quenching by BrPC in the
outer membrane leaflet (Fig. 3 b) infers that the entire
quenching by BrPC (Figs. 2, 3 a) must occur in the inner
leaflet, with the associated peptide consequently resid-
ing in the interface of the inner membrane leaflet.
Reexamination of the bilayer asymmetry of CUGA
showed that no redistribution (flip-flop) of Br4PC occurs
during the peptide uptake experiments. Other control
experiments concern the stability of the ion gradient
maintained by the asymmetric Br4PCin/PC0.t vesicles.
Membrane potential measurements employing diS-C2-
(5) carried out after the incubation with the peptide,
yielded responses which were indistinguishable for the
asymmetric vesicles and the symmetric 20% Br4PC
containing LUV (data not shown). The two vesicle types
used in the experiments described above (Fig. 3) yield
different AIXme+ fluorescence responses upon applying
a K+ diffusion potential (see Discussion).
The roles of AW, ApH, and pH
To elucidate the mechanism by which the peptide
attains a localization in the interface of the inner bilayer
leaflet, the involvement of the pH gradient and the
influence of the pH have been investigated. It is well
established that due to the proton permeability of the
lipid bilayer, a K+ diffusion potential evokes a transbi-
layer pH gradient (Nichols et al., 1980; Cafiso and
Hubbell, 1983; Redelmeier et al., 1989).
In Fig. 4, the time course of AIXme+ uptake assayed
by gel filtration on minicolumns is shown (a). In parallel,
the concomitant changes in Aq and ApH were deter-
mined from TPP+ and MeAm distribution (b and c). In
the absence of ionophores, the K+/Na+ gradient induces
a slowly proceeding uptake of peptide that was not
discerned previously (de Kroon et al., 1989). Ai measure-
ments reveal the gradual development of a potential up
to a log ([TPP]hl/[TPP+]OUt) value of -1.4 after 2 h
under these conditions (data not shown).
In the absence of peptide, valinomycin induces a
stable Aq,, corresponding to log ([TPP ]ij[TPP ]ot)
- 3.8, that gives rise to the gradual building up of a pH
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FIGURE 4 (a) Time course of ion gradient induced vesicle accumula-
tion of AIXme+ assayed by the minicolumn method. Aliquots were
taken from incubations of 0.1 mM AIXme+ and 1 mM PC LUV with
K+ at both sides of the membrane (-) or exhibiting a K+/Na+ gradient
in the absence (0) and presence of valinomycin (-, valUPC = 10-3)
and in the presence of both FCCP and valinomycin (A, FCCP/
PC = 1.3 * 10-4, val/PC = 10-3). (b, c) In parallel, the effect of AIXme+
on ,A (b) and ApH (c) was determined. For this purpose [3H]TPP+
and ['4C]MeAm were included in incubations with (closed symbols,
drawn lines) and without (open symbols, dashed lines) AIXme+ present.
Results are shown for yn+/Na.,' vesicles with valinomycin (squares)
and both FCCP and valinomycin present (triangles). Conditions as in a.
The error in the peptide association (a) amounts to 10%; the absolute
error in the TPP+ (b) and MeAm (c) distribution data is + 0.2.
gradient that amounts to 1.4 pH units after 2 h
(Figs. 4 b and c), in agreement with Mayer et al. (1988).
With the uptake ofAIXme+, which is present at Ri = 10,
the membrane potential is gradually dissipated, whereas
remarkably, the decline of the pH gradient does not set
in until - 50 min after starting the incubation (Fig. 4 c).
The latter observation suggests that the interaction of
the peptide with the vesicle membrane accelerates the
development of the K+ diffusion potential-induced pH
gradient. The influence of the peptide on the K+
diffusion potential dependent pH gradient is obvious
when the induced pH gradient is measured as function
of the applied K+ gradient in the absence and presence
of the peptide at Ri = 10, as shown in Fig. 5. The
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FIGURE 5 ApH as a function of the applied transmembrane K+
gradient in the absence (0) and presence of peptide at a lipid/peptide
molar ratio of 10 (0). The pH gradient was determined from the
MeAm distribution in a 1 mM PC incubation, 30 min after the addition
of valinomycin (val/PC = 10-3). The internal buffer was 150 mM
K2SO4, 20 mM Hepes pH 7.0, the isoosmotic external buffer contained
various ratios of K2SO4/Na2SO4, 20mM Hepes pH 7.0.
apparent threshold dependence on the K+ gradient for
the induction of a pH gradient in the absence of peptide,
and the increased acidification of the vesicle interior
under the influence of the compound taken up, have
been reported previously (Mayer et al., 1988; Redel-
meier et al., 1989).
FCCP renders the membrane permeable to protons.
The presence of both valinomycin and FCCP should give
rise to A* and ApH values corresponding to electrochem-
ical equilibrium between the electrical potential and the
induced pH gradient (Redelmeier et al., 1989). Under
these conditions, a ApH of 2.7 units is measured with the
value of log([TPP+]i./[TPP+]..,) amounting to 3.4
(Figs. 4 b and c). The discrepancy observed between log
([TPP+],/[TPP+]0ut) and log ([MeAm]1,,/[MeAm]out) may
partly be due to membrane binding of TPP+ (see
Methods). When both FCCP and valinomycin are
present, the rate of the peptide uptake is increased over
that occurring in the presence of valinomycin alone, but
the maximum level of uptake is similar in both cases.
The fast peptide accumulation in the val/FCCP system is
paralleled by an immediate reduction of A*4 and ApH
(Fig. 4). The strong reduction of the ApH points to a
buffering of the internal pH by the peptide taken up, and
was also observed in experiments using PC LUV with
applied pH gradients (data not shown).
The data at this point seem to indicate that the pH
gradient evoked by the K+ diffusion potential, is the
primary cause of the uptake of AIXme+. However, a
comparison of the residual pH gradients remaining after
the uptake of similar amounts of peptide in response to
valinomycin alone and to both FCCP and valinomycin
(Figs. 4 a and c), tentatively suggests a contribution by
At4 to the uptake process other than the mere induction
of the pH gradient.
The investigation of this putative additional role for
A4i has been pursued in the fluorescence experiments
where a much lower peptide/lipid ratio is used (Ri = 150).
These conditions are expected to enable a better distinc-
tion between the roles of A* and ApH, as the profound
enhancement by the peptide of the K+ diffusion potential-
induced pH gradient to a level which is disguised due to
buffering by the internalized peptide, will be minimized.
Furthermore, to neutralize the K+ diffusion potential-
induced pH gradient, these experiments have been
performed in phosphate buffered systems which have a
greater buffering capacity than the systems used so far.
The experiments were carried out at pH 6, 7, and 8 to
assess the role of the protonation degree of the peptide.
Upon addition of valinomycin, the phosphate-buffered
vesicle systems in the presence of AIXme+ at Ri = 150
display a Atf characterized by log ([TPP Ii,[TPPI]out)
distributions in excess of 3.4, without any detectable pH
gradient until at least 30 min after valinomycin addition,
irrespective of the pH. As is shown in Fig. 6, under these
conditions a modest AIXme+ fluorescence increase at
pH 7.0 is apparent (cf Fig. 1) which is larger than that at
pH 8.0 whereas at pH 6.0 there is no fluorescence
change.
Upon addition of both valinomycin (val/PC = 10-')
2.1F \
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FIGURE 6 AIXme+ fluorescence increases recorded in phosphate
buffered systems exhibiting a K.+/Na..,+ gradient at different pH
values. LUV were prepared in 200mM KPi at pH 6.0 (triangles), pH 7.0
(circles), or pH 8.0 (squares) and the nonenclosed buffer was replaced
by 200 mM NaP, adjusted to the same pH. Valinomycin (val!
PC = 10-, open symbols) or both FCCP and valinomycin (FCCP/
PC = 1.3 - 10-4, val/PC = 10', closed symbols) were added at t = 0 to
300 ,uM PC LUV, 2 ,uM AIXme+.
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and FCCP (FCCP/PC = 1.3@10-') the rate and the
extent of the fluorescence increase at pH 8.0 is tremen-
dously enhanced, at pH 7.0 this enhancement is less
dramatic whereas at pH 6.0 no change is observed
(Fig. 6). Under these conditions a log ([TPP ],fi/[TPP']out)
value of 3.1 is measured irrespective of the pH, and the
induced pH gradients amount to 1.55 at pH 6.0, 1.93 at
pH 7.0, and 1.85 at pH 8.0 after 30 min. The data seem to
indicate that the relative roles of Ai and ApH in the
peptide uptake process depend on the protonation
degree of the peptide.
Peptide and lipid specificity
Qualitatively similar results as reported above for
AIXme+ have been found for its pentamerous analogue
AXme+. However, the efficiency of peptide uptake is
less for this peptide (de Kroon et al., 1989). This
difference is also evident from the time course of
tryptophan fluorescence changes (data not shown).
To find out whether a K+ diffusion potential (negative
inside) also affects the membrane interaction of pep-
tides carrying more than one positive charge, two diva-
lent positively charged peptide analogues of AXme+
were examined. Neither AXetN2", with a NH3+-moiety
at each end of the molecule, nor RXme2" with a NH3+-
and a side chain guanidinium group at the NH2-terminus
of the molecule, showed any response to, or effect on a
K+ diffusion potential, as judged from both fluorescence
and minicolumn experiments in which peptide associa-
tion and Atp dissipation (TPP+) were assayed. Not even
at external pH values in the range 8-9, where deprotona-
tion is expected to neutralize at least one of the positive
charges, was any effect detectable (data not shown).
The introduction of a negative surface charge greatly
enhances the affinity of the positively charged peptides
for phospholipid bilayers, which could influence the
effect of ion gradients on the peptide-membrane interac-
tion. Because previously the interaction of these pep-
tides with SUV consisting of the acidic phospholipid CL
has been characterized (de Kroon et al., 1990), this
possibility was analyzed by incorporating CL into the
LUV and studying the K+ diffusion potential-induced
peptide association. The presence of CL tends to en-
hance the initial rate of the fluorescence increase of
AIXme+ (Fig. 7). In the absence of valinomycin, at 50%
CL incorporation, AIXme+ fluorescence also increases
(Fig. 7). This can probably be accounted for by the
increased K+ permeability due to CL incorporation (cf
Mayer et al., 1985). TPP+ distribution data revealed that
with increasing CL contents the ability of the vesicles to
maintain a stable Atj is impaired (even though this effect
was partly masked by enhanced TPP+ binding due to the
negative surface charge; data not shown). This deterio-
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FIGURE 7 The fluorescence change of AIXme+ in response to a
valinomycin induced K+ diffusion potential applied to PC (E), PC/CL
3/1 (@), and PC/CL 1/1(A) vesicles compared to that of the peptides
RXme2" (A) and AXetN2+ (0) in response to PC/CL 1/1 vesicles
under the same conditions. The fluorescence increase of AIXme+ in
the presence of PC/CL 1/1 without valinomycin added is also shown
(A). Valinomycin was added at t = 0 to 300 p.M LUV, 2 ,uM peptide at
a valinomycin/phospholipid molar ratio of 10'-. Buffers as in Fig. 1,
containing 2 mM EDTA. The fluorescence increase is related to that
at t = 0 (F/FO), disregarding the initial fluorescence increase due to
spontaneous peptide-vesicle association (F/FO), (1.3 for RXme2" and
AXetN2+, and 1.2 for AIXme+ in the presence of PC/CL 1/1; 1.1 for
AIXme+ in the presence of PC/CL 3/1).
rating stability is reflected in the maximum factor of
fluorescence increase becoming smaller as more CL is
incorporated, and in the subsequent fluorescence de-
cline observed for PC/CL 1/1 (Fig. 7).
In contrast to AIXme+ the divalent peptides AXetN2+
and RXme2" (Table 1) do not show any additional
change in fluorescence after the initial increase due to
"spontaneous" binding (Fig. 7 legend) upon applying a
K+ diffusion potential to vesicles consisting of PC/CL 1/1
at pH 7.0 (Fig. 7). The same negative result was ob-
tained at external pH values up to 8.7 and at PC/CL
molar ratios of 3/1 and 9/1 (data not shown).
The RET assay (see Methods) monitors energy trans-
fer from the associated peptide's tryptophan to mem-
brane incorporated DNS-PE and allows the use of much
higher peptide concentrations. Application of this assay
to AIXme+ reveals an increased energy transfer effi-
ciency in response to a K+ diffusion potential, which is
consistent with the tryptophan fluorescence data except
for the earlier onset of the fluorescence decline (cf
Figs. 7 and 8). The latter is accounted for by the larger
amount of peptide destabilizing the ion gradient under
the conditions of the RET assay. The divalent peptides
in the presence of PC/CL vesicles at a lipid/peptide
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FIGURE 8 The effect of a valinomycin-induced K+ diffusion potential
on peptide-lipid vesicle interaction monitored by resonance energy
transfer. DNS-PE was incorporated at 2% in PC/CL 3/1 (closed
symbols) and PC/CL 1/1 vesicles (open symbols). At t = 0 the peptides
AIXme+ (triangles), RXme2" (circles) and AXetN2" (squares) were
added at a concentration of 20 ,uM to 200 FM LUV exhibiting a
Kn+/Na..,+ gradient. Valinomycin was introduced at t = 2 min
(val/PC = 10-4). The fluorescence intensity I is related to Io the
fluorescence emitted by the vesicles in the absence of peptide.
molar ratio of 10 revealed a small membrane potential
driven energy transfer increase for RXme2" which was
larger at 50% than at 25% CL incorporation (Fig. 8). In
contrast, the peptide AXetN2' appears not to be suscep-
tible to membrane potential up to PC/CL ratios of 1/1
although it does show significant vesicle association,
apparent from the initial fluorescence level (I/IO at t = 0
in Fig. 8). FCCP does not affect the valinomycin induced
RET changes of the divalent peptides (data not shown).
To examine whether oppositely charged peptide ana-
logue of AIXme+ are likewise affected by ion gradients
with a reversed polarity, the anionic peptides bocAX-
and bocAIX- were tested using vesicles exhibiting a Na+
inside/K+ outside gradient. Fig. 9 shows the results at
pH 5: the peptide bocAIX- shows a valinomycin induced
fluorescence increase that is enhanced in the presence
of FCCP, and that can be reversed by NFG (data not
shown); also in the absence of valinomycin the ion
gradient gives rise to a gradual fluorescence increase.
The less hydrophobic peptide boxAX- displays consis-
tent changes in fluorescence although to a lesser extent
(Fig. 9). At pH 4 the rate, but not the extent, of the
fluorescence increase is enhanced, whereas at pH 6
there is hardly a significant membrane potential effect
detectable (data not shown). As was found for AIXme+
and AXme+ the fluorescence responses of the anionic
peptides are highly dependent on the pH of the system
as well as on the hydrophobicity of the peptide.
FIGURE 9 Effect of a reversed ion gradient, Nai.+/KO,,+, on the
tryptophan fluorescence of anionic peptides at pH 5.0. Peptides were
added at 2 FM to PC LUV prepared in 150mM Na2SO4, 10mM HMG
pH 5.0 and diluted to 300 FM in 150mM K2SO4, 10mMHMG pH 5.0.
Data are shown for bocAX- in the absence (0) and presence of
valinomycin (0) and for bocAIX- under the same conditions (-, A),
and with both FCCP and valinomycin present (A) and in the absence
of an ion gradient (O, Nai,+/Na0.,+). Valinomycin and FCCP were
added at t = 0 to ratios of 10-4 and 1.3 - 10-4 with respect to PC,
respectively.
DISCUSSION
The K+ diffusion potential-enhanced vesicle association
of peptides carrying a single positive charge, previously
established in a gel filtration assay (de Kroon et al.,
1989) is paralleled by an increase of the fluorescence
emission intensity of the peptides' intrinsic tryptophan
residue. The first method allows the quantitation of the
amount of peptide associated. The second method
enables the localization of the associated peptide mole-
cules in the vesicle.
Quenching of tryptophan fluorescence by brominated
phospholipids that serve as a molecular ruler of inser-
tion depth, demonstrated that the associated peptide is
preferentially localized in the membrane-solution inter-
face. The accumulation of peptide in the interface of the
inner and not the outer membrane leaflet of the PC
vesicles was unambiguously demonstrated in two comple-
mentary experiments, in which asymmetric PC vesicles
were used either containing BrPC in the inner and
eggPC in the outer leaflet of the bilayer, or containing
BrPC exclusively in the outer leaflet of the membrane
(Fig. 3). The results of these experiments imply that the
entire fluorescence increase observed for AIXme+ in
response to a K+ diffusion potential is due to the
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internalized peptide and not to peptide adsorbed at the
outside of the vesicles.
A comparison of the AIXme+ fluorescence responses
in the presence of LUV differing in trapped volume
(LUVET 400 and LUVET 200, data not shown) reveals
a faster and larger fluorescence increase for the smaller
vesicle type. This is consistent with the fluorescence
increase reflecting the internal peptide concentration
dependent partioning of peptide into the bilayer. Estimat-
ing from the data that under the conditions of the
fluorescence experiments (lipid/peptide ratio of 150) the
amount of accumulated peptide is in the order of50% of
the total amount of peptide present, a theoretical
peptide concentration of - 1 mM inside the LUVET 400
(trapped volume: 3 p,l/,mol) can be calculated. At this
peptide concentration considerable membrane partition-
ing is expected (cf de Kroon et al., 1990). The rapid
return of the fluorescence intensity to its initial level
upon dissipation of the ion gradient rules out the
formation of large peptide aggregates within the vesi-
cles.
In the minicolumn gelfiltration experiments (lipid/
peptide ratio of 10) the calculated, theoretical internal
peptide concentration attained upon application of a K+
diffusion potential would amount to 10 mM. Conse-
quently the effects exerted by the membrane inserted
peptide on the ion gradient stability are much more
profound under these conditions than under the condi-
tions of the fluorescence assay.
The peptide was shown to affect the ion gradients in
two ways: (a) It increases the ion permeability of the
lipid bilayer resulting in the acceleration both of the
AtJ-induced proton gradient development (Figs. 4 c and
5), and of the eventual dissipation of the ion gradients
(Fig. 4). (b) The internalized peptide increases the pH
inside the vesicles (Fig. 4 c). The latter is also apparent
from the data presented in Fig. 10, where the AIXme+
fluorescence intensity read 30 min after the addition of
valinomycin is plotted against the K+ gradient applied to
the PC LUV, for lipid/peptide molar ratios of 250 and
150. There is a striking difference in curve shape under
these two conditions. Whereas at 500 ,uM PC, the shape
of the curve is sigmoidal resembling that obtained for
potential sensitive fluorescence probes such as safranine
(Woolley et al., 1987), at 300 p.M the K+ gradient
dependence of the fluorescence increase displays a
distinct "dip." This characteristic is probably due to the
buffering capacity of the internalized peptide that coun-
terbalances the induced pH gradient in that particular
range of the initially applied A+. At 500 p,M PC this
effect is not apparent because in the range of K+
gradients studied the maximum attainable internal con-
centration of peptide is too low to affect ApH, due to the
larger internal volume available. This result confirms the
F/Fo
FIGURE 10 The K+ diffusion potential-induced AIXme+ fluorescence
increase 30 min after the addition of valinomycin plotted against the
applied K+ gradient. Cuvette solutions contained 2 ,uM AIXme+ and
either 300 F.M (A) or 500 ,uM PC LUV (O). Other conditions as in
Fig. 5.
importance of the pH gradient for the peptide uptake
and underscores the sensitivity of the fluorescence assay.
Likewise, the ApH probe MeAm which is used at a
relatively high concentration (see Methods) may affect
the internal pH of the vesicles if the buffering capacity in
the vesicle lumen is limited.
With respect to the mechanism of the peptide accumu-
lation, the obvious importance of the pH gradient
implies that membrane translocation of the depro-
tonated form provides a major, if not the only contribu-
tion to the process. Proton-gradient driven vesicle up-
take of weak bases due to the high permeability of the
neutral form is well established for a large number of
compounds containing an amino function (Nichols and
Deamer, 1976; Mayer et al., 1986b; Bally et al., 1988). In
several cases however, the uptake of these compounds in
response to a K+ diffusion potential could not be entirely
accounted for by the AI-induced pH gradient, suggest-
ing that Aqi may be able to drive the uptake of the
protonated, charged form of the molecules (Mayer et al.,
1988; Bally et al., 1988).
The fluorescence experiments employing phosphate
buffered systems suggest that the relative contributions
of Aq; and ApH to the uptake of the peptide depend
strongly on the pH and consequently on the protonation
degree of AIXme+ (Fig. 6). The typical pK. value of a
NH2-terminal amino group in a peptide is 8.0 (Stryer,
1981). At pH 6, where most of the peptide molecules are
in the protonated, charged state, no significant peptide
uptake occurs, irrespective of the presence of a pH
gradient, inferring that only membrane translocation of
the uncharged molecule can occur. Accordingly, at the
higher pH values in the presence of both valinomycin
and FCCP, the efficiency of peptide uptake reflects the
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deprotonation degree of the peptide. If only valinomycin
is present, the uptake is drastically reduced. However,
interestingly, under these conditions the fluorescence
increase recorded at pH 7 is distinctly larger than that at
pH 8.
The latter result could be interpreted as a direct
influence of A* on the charged peptide, that can only
reveal itself if the peptide is translocation competent,
i.e., when the pH allows the peptide to deprotonate. The
possibility that the fluorescence increase at pH 7 origi-
nates from peptide adsorbed to the outside surface of
the vesicle is considered highly unlikely in view of the
virtual absence of a fluorescence increase at pH 6 and in
view of the results obtained using the asymmetric
vesicles containing BrPC exclusively in the outer leaflet
(Fig. 3 b).
The data are consistent with the following uptake
mechanism. The K+ diffusion potential driven vesicle-
accumulation of peptides with a single ionizable amino
function is primarily the result of a redistribution of a
weak base across the bilayer in response to the ApH
induced by the Al. This mechanism infers that the
neutral species of the peptide crosses the bilayer and
explains the strong pH dependence of the process. The
efficiency of transbilayer diffusion will depend on the
permeability coefficient of the peptide. The membrane
permeability coefficient of a solute, Pm on its turn,
depends on the solute's partition coefficient a (=Cm/Ca,
where cm and ca denote the peptide's concentrations in
the membrane and aqueous phase, respectively) accord-
ing to Pm = a * Dm/bm, where Dm is the solute's diffusion
coefficient in the membrane and bm the thickness of the
membrane's hydrophobic core (Andersen, 1989). Possi-
bly, Aqj is able to attract the protonated form of the
peptide promoting its insertion into the membrane. This
would shift to some extent the dynamic equilibrium
between the free and membrane partitioned form of the
protonated peptide in favor of the latter, leading to an
enhancement of peptide permeation if the outside pH
permits deprotonation. Without a ApH present, the
translocated peptide is expected to immediately flow
back to the external aqueous phase. Nevertheless, a
small A*-induced net inward flux can be detected which
is greater at pH 7 than at pH 8 (Fig. 6), in agreement
with the notion that Aqf would affect the charged species
of the peptide.
An alternative explanation for the effects that so far
have been attributed to Aqp takes into account the
existence of unstirred layers adjacent to the membrane.
These are likely to influence, and to be influenced by, an
accumulation of peptide in the membrane-water inter-
face. It is conceivable that in the presence of a K+
diffusion potential, the pH in the stagnant aqueous
solution adjacent to the bilayer is lower than the pH of
the bulk solution inside the vesicle which is measured by
MeAm. This difference may be larger at pH 7 than at pH
8, simply because it takes more protons to create a local
pH difference at pH 8 than at pH 7. In addition, once the
peptide has been taken up, appreciable pH differences
are likely to develop across the unstirred layers as a
result of the concentration polarization of the unionized
species (Gutknecht and Tosteson, 1973; Andersen, 1989),
that limit the permeation of the peptide. The latter
phenomenon probably accounts for the development of
the fluorescence increase in the absence of a bulk ApH
at pH 7 and pH 8 (Fig. 6), irrespective of the first cause
of the uptake being a direct Afi effect or the initial pH
gradient between the unstirred layers.
The introduction of a negative surface charge by
incorporation of CL into the vesicles will increase the
peptide's concentration at the membrane surface lead-
ing to an enhanced partitioning of AIXme+ into the
membrane (de Kroon et al., 1990), which is expected to
promote the K+ diffusion potential-induced peptide
uptake, provided that the changes in ion gradient
stability do not interfere. On the contrary, the lower
surface pH arising from the negative surface charge
(MacDonald et al., 1976) is likely to inhibit the depro-
tonation of the peptide that is required for uptake. The
experiment reveals an AIXme+ fluorescence response of
which the initial rate appears to increase with increasing
CL contents up to 50% of the total lipid (Fig. 7),
indicating that under these conditions the effect of the
negative surface charge on the partition coefficient of
the peptide is greater than the concomitant effects on
the surface pH and the stability of the ion gradient. The
effect of the lower surface pH on peptide permeation is
apparent from the rate of the NFG-induced decline of
the AIXme+ fluorescence, which reflects the peptide's
release and which is slower at higher CL contents (data
not shown).
The lower uptake efficiency of AXme+ into PC LUV
as compared to AIXme+ is accounted for by the depen-
dence of the bilayer partitioning on the peptide's hydro-
phobicity (de Kroon et al., 1989; 1990). Likewise, the
fluorescence increase recorded for the anionic peptide
bocAIX- is larger than that for its less hydrophobic
analogue boxAX- in the presence of vesicles exhibiting
"reversed," i.e., Na n'/K.,ut gradients (Fig. 9). The re-
sults obtained in this system comply in all respects with
the mechanism proposed for the uptake of AIXme+.
The pH dependence of the K' gradient induced fluores-
cence increase again reflects that only the neutral,
protonated, species of the peptides can pass the bilayer,
and is in agreement with the PKa value of 3.1 of the
COOH-terminal carboxyl moiety of peptides (Stryer,
1981). The extents of the fluorescence increases ob-
tained at pH 5 (Fig. 9) and at pH 4 (data not shown) are
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smaller than those obtained for AIXme+ in the system
of opposite polarity for reasons inherent to the system:
(a) The inward leakage of K+ leads to faster dissipation
of the ion gradient than the outward leakage in the
reversed system. (b) The Ak-induced ApH will be
smaller in the relevant pH range as more protons will
have to permeate in order to generate a pH gradient. (c)
The anionic peptides exert a stronger influence on the
membrane ion permeability for ions than AIXme+
because of a more efficient membrane partitioning
resulting from their greater hydrophobicity (de Kroon et
al., 1990). The faster initial rate of the fluorescence
increase of the anionic peptides as compared to that of
AIXme+ (cf Figs. 1 and 9) and the occurrence of a
fluorescence increase of bocAIX- without valinomycin
present, are accordingly explained by the hydrophobicity
of the peptides.
The absence of any ion gradient-induced response of
the divalent positively charged peptides AXetN2" and
RXme2" as detected by the gel filtration assay and by the
tryptophan fluorescence measurements, is interpreted
as the inability of these peptides to move across the lipid
bilayer under the conditions tested. The most likely
explanation for this translocation incompetence is pro-
vided by the combination of a lack of partitioning into
pure PC bilayers by these peptides (de Kroon et al.,
1990) and the impossibility to deprotonate to the neutral
form which is due to the pKa value of 12.0 of the
arginine side chain (Stryer, 1981) in RXme2+, and
probably caused by the low surface pH of the CL
containing vesicles in the case of AXetN2 .
However, under the conditions of the RET assay, with
CL incorporated into the LUV and with a large amount
of peptide present, an increase in tryptophan-dansylPE
energy transfer in response to the K+ diffusion potential
is apparent for RXme2 , which is small and fast com-
pared to that observed for AIXme+. In contrast, the
peptide AXetN2' does not show any response to AiJ
under these conditions (Fig. 8). This is remarkable since
both divalent peptides share a comparable affinity for
negatively charged membranes (de Kroon et al., 1990,
1991). Since the divalent peptides are not expected to
readily permeate across the vesicles membrane as ar-
gued above, the Al,-induced RET increase observed for
RXme2+ is attributed to an enhanced binding of this
peptide to the outside of the vesicles due to the
attraction by Aq. The difference in susceptibility to A*
found for RXme2' and AXetN2+ may be related to the
different modes of membrane anchoring of these pep-
tides (de Kroon et al., 1990). The difference between
peptides carrying one and two charged groups with
respect to their membrane translocation competence,
has previously been inferred in a study where the lipid
accessibility to the peptides was investigated by 2H-
NMR (de Kroon et al., 1991a).
In conclusion, amphiphilic peptides with a single
ionizable moiety were shown to permeate across phos-
pholipid bilayers. This process is enhanced by a trans-
membrane pH gradient of the appropriate polarity
resulting in an accumulation of the peptide inside the
phospholipid vesicles. Although a direct stimulation of
the uptake by A* cannot be excluded, this possibility is
considered less likely in view of the very small effect
exerted by Aip on the divalent peptide. The putative "Ad4
effect" on the uptake ofAIXme+ might as well be due to
the unstirred layer phenomena discussed above.
The findings described in this study may be relevant
for the absorption of small peptides that occurs in the
intestine and in the kidney. It has been reported that ion
gradients stimulate the uptake of these substrates into
brush-border membrane vesicles isolated from these
tissues (see Tiruppathi et al., 1990). The finding that a
membrane potential is able to influence the membrane
partitioning of charged peptides may contribute to the
understanding of the role membrane potential plays in a
number of biological processes e.g., in mitochondrial
protein import (Hartl et al., 1989). The effect of a
membrane potential on the interaction of biological
active peptides with phospholipid vesicles has been
addressed in a parallel study (de Kroon et al., 1991b).
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